Nicox S.A. (ALCOX.PA)

EUR 0.23

(1.02%)

Gross Profit Summary of Nicox S.A.

Nicox S.A.'s latest annual gross profit in 2023 was -11.5 Million EUR , down -148.83% from previous year.
Nicox S.A.'s latest quarterly gross profit in 2023 FY was -11.5 Million EUR , down -148.83% from previous quarter.
Nicox S.A. reported a annual gross profit of 23.55 Million EUR in annual gross profit 2022, up 225.69% from previous year.
Nicox S.A. reported a annual gross profit of 7.23 Million EUR in annual gross profit 2021, down -43.96% from previous year.
Nicox S.A. reported a quarterly gross profit of -11.5 Million EUR for 2023 FY, down -148.83% from previous quarter.
Nicox S.A. reported a quarterly gross profit of -2478.50 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Nicox S.A. (2023 - 2019)

Historical Annual Gross Profit of Nicox S.A. (2023 - 2019)

Year	Gross Profit	Gross Profit Growth
2023	-11.5 Million EUR	-148.83%
2022	23.55 Million EUR	225.69%
2021	7.23 Million EUR	-43.96%
2020	12.9 Million EUR	0.0%
2019	- EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2023 Q1	-2478.50 EUR	40.8%
2023 FY	-11.5 Million EUR	-148.83%
2023 Q2	-2478.50 EUR	0.0%
2022 FY	23.55 Million EUR	225.69%
2022 Q4	-4186.50 EUR	0.0%
2021 FY	7.23 Million EUR	-43.96%
2020 FY	12.9 Million EUR	0.0%
2019 FY	- EUR	0.0%

Peer Gross Profit Comparison of Nicox S.A.

Name	Gross Profit	Gross Profit Difference
European Medical Solutions	13.51 Million EUR	185.138%
FERMENTALG	535 Thousand EUR	2250.093%
argenx SE	925.49 Million EUR	101.243%
BioSenic S.A.	543 Thousand EUR	2218.416%
Celyad Oncology SA	33 Thousand EUR	34957.576%
Hyloris Pharmaceuticals SA	1.99 Million EUR	676.881%
Onward Medical N.V.	-14.81 Million EUR	22.371%
Oxurion NV	104 Thousand EUR	11160.577%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	967.496%
Financière de Tubize SA	-2.02 Million EUR	-466.766%
UCB SA	3.34 Billion EUR	100.344%